References
- Vrabec DP. The inverted Schneiderian papilloma: a 25-year study. Laryngoscope 1994; 104: 582–605
- Lawson V, Ho BT, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope 1995; 195: 282–8
- De Filippis C, Marioni C, Tregnaghi A, Marino F, Staffieri A. Primary inverted papilloma of the middle ear and mastoid. Otol Neurotol 2002; 23: 555–9
- Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancer. Proc Natl Acad Sci U S A 1983; 80: 560–3
- Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, et al. Increased proteasome-dependent degradation of the cyclin dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinoma. Nat Med 1997; 3: 231–4
- Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-p16 E7 oncoprotein. Genes Dev 1997; 11: 2090–100
- Hsu SM, Raime L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
- Marioni G, Altavilla G, Busatto G, Blandamura S, De Filippis C, Staffieri A. Detection of human papilloma virus in temporal bone inverted papilloma by polymerase chain reaction. Acta Otolaryngol 2003; 123: 467–71
- Armitage P, Berry G. Statistical methods in medical research3rd edn. Blackwell Scientific Publications, Oxford 1994; 1234
- Barnes L, Tse LLY, Hunt JL. Schneiderian papillomas. WHO classification of tumours, pathology & genetics of head and neck tumours, L Barnes, JW Eveson, P Reichart, D Sidransky. IARC Pres, Lyon 2005
- Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002; 21: 1510–17
- Beck JC, McClatchey KD, Lesperance MM, Esclamando RM, Carey TE, Braford CR. Presence of human papilloma virus predicts recurrence of inverted papilloma. Otolaryngol Head Neck Surg 1995; 113: 49–55
- Buckwald C, Lindeberg H, Pedersen BL, Franzmann MB. Human papilloma virus and p53 expression in carcinoma associated with sinonasal papillomas: a Danish epidemiological study 1980–1998. Laryngoscope 2001; 111: 1104–10
- Caruana SM, Zwiebel N, Cocker R, McCormick SA, Eberle RC, Lazarus P. p53 alteration and human papilloma virus infection in paranasal sinus cancer. Cancer 1997; 79: 1320–8
- Cheung TH, Lo KW, Yu MM, Yim SF, Poon CS, Chung TK, et al. Aberrant expression of p21 (WAF1/CIP1) and p27(KIP1) in cervical carcinoma. Cancer Lett 2001; 172: 93–8
- Kim YT, Cho NH, Park SW, Kim JW. Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma. Gynecol Oncol 1998; 71: 38–45
- Skomedal H, Kristensen GB, Lie AK, Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 1999; 73: 223–8
- Katori H, Nozawat A, Tsukuda M. Relationship between p21 and p53 expression, human papilloma virus infection and malignant transformation in sinonasal-inverted papilloma. Clin Oncol (R Coll Radiol) 2006; 18: 300–5
- Katori H, Nozawa A, Tsukuda M. Cell proliferation, apoptosis, and apoptosis inhibition in malignant transformation of sinonasal inverted papilloma. Acta Otolaryngol 2007; 127: 540–6
- Busquets JM, Hwang PH. Endoscopic resection of sinonasal inverted papilloma: a meta-analysis. Otolaryngol Head Neck Surg 2006; 134: 476–82